Vor Biopharma raises $75M in private placement at $14.05/share, diluting shareholders 10%

Filed March 27, 2026 · Period ending March 26, 2026 · ~1 min read

Key Changes

• high

  Company sold 5.3M shares at $14.05 to TCGX-affiliated investors for $75M gross proceeds, closing March 30. Funds will advance clinical pipeline and general operations.

  Item 1.01 verify on EDGAR →
• high

  Private placement creates ~10% dilution, increasing outstanding shares from 48.8M to 54.2M. Existing shareholders' ownership percentage reduced proportionally.

  Item 1.01 verify on EDGAR →
• medium

  Company must file resale registration within 30 days and get it effective within 60 days or face liquidated damages. Once registered, new shares become freely tradable.

  Item 1.01 verify on EDGAR →